Connect with us

AI Research

Artificial Intelligence (AI) Software Sales Could Soar 580%: 2 AI Stocks to Buy Now (Hint: Not Palantir)

Published

on


Artificial intelligence (AI) is quickly weaving its way into daily life. According to Goldman Sachs, 9.2% of U.S. companies now use AI to produce goods and services, which is twice the percentage that used the technology at the same time last year. But the market is still in its early stages.

Morgan Stanley estimates AI software revenues will increase 580% in the next three years, topping $400 billion in 2028. While Palantir is well positioned to benefit, the stock carries a steep valuation. Investors should consider more reasonably priced stocks such as MongoDB (MDB 3.40%) and Okta (OKTA 0.98%).

Read on to learn more.

Image source: Getty Images.

1. MongoDB

Databases are used to store, manage, and retrieve application data. MongoDB’s document database handles structured and unstructured data, which differentiates it from traditional relational databases designed solely for structured data. To elaborate, structured data fits neatly into rows and columns, but unstructured data (e.g., images, videos, and text) does not.

The flexibility of the document model means MongoDB is especially well-suited for content management systems, e-commerce platforms, and artificial intelligence (AI) applications. MongoDB earlier this year leaned into the AI opportunity by acquiring Voyage AI, a company that develops embedding and reranking models that improve AI application accuracy.

CEO Dev Ittycheria told analysts, “As AI redefines how applications are built and how businesses operate, MongoDB is exceptionally well positioned. Real-world applications require high-quality, context-rich, and often unstructured data to deliver trustworthy outputs.”

MongoDB’s document model is also well-suited to real-time analytics applications, which are often used to personalize customer experiences across the internet. Consultancy Gartner recently ranked MongoDB as a leader in database management systems, mentioning its support for artificial intelligence and real-time analytics.

MongoDB shares currently trade at 49 times adjusted earnings. While that is not cheap, the valuation is reasonable for a company whose adjusted earnings increased 96% in the most recent quarter. Additionally, shares trade at 7.4 times sales, a material discount to the one-year average of 9.5 times sales and the three-year average of 13.4 times sales.

2. Okta

Okta is a cybersecurity company that develops identity and access management (IAM) software. Its platform lets administrators enforce contextual access policies that define which users and devices can connect to which applications and resources. It leans on AI to score risk with each login and authenticate accounts (including AI agents) based on criteria like identity, location, and behavior.

Importantly, Okta recently introduced a new product called Identity Threat Protection, an AI-powered tool that measures session risk. To elaborate, whereas login risk is calculated only one time during the authentication phase, session risk is determined continuously by analyzing every request post-authentication.

Okta has multiple tailwinds at its back. First, cybersecurity is a nondiscretionary budget expense because businesses cannot afford to suffer a data breach. Second, identity-based attacks account for 30% of cybersecurity incidents, and the identity market is projected to grow at 12.6% annually through 2030 as AI creates new threats. Third, industry analysts recently ranked Okta as a leader in workforce identity (for employees) and customer identity.

Okta shares currently trade at 33 times adjusted earnings. That is quite reasonable for a company whose adjusted earnings increased 32% in the most recent quarter. Additionally, shares currently trades at 6.6 times sales, roughly in line with the three-year average of 6.5 times sales. The stock fell after the recent earnings report because management provided cautious guidance. Patient investors should lean into that opportunity.

Trevor Jennewine has positions in Palantir Technologies. The Motley Fool has positions in and recommends Goldman Sachs Group, MongoDB, Okta, and Palantir Technologies. The Motley Fool recommends Gartner. The Motley Fool has a disclosure policy.



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

AI Research

Lila Sciences raises $235 million to expand AI-driven research platform | Pharmaceutical | The Pharmaletter

Published

on


Lila Sciences has secured $235 million in series A financing, co-led by Braidwell and Collective Global, at a valuation of about $1.23 billion. The Massachusetts-based company, founded by Flagship Pioneering in 2023, is building an artificial intelligence platform designed to automate and accelerate the scientific method across multiple disciplines.

The latest financing follows a $200-million seed round in March and will be used to hire staff and open new sites in Boston, San Francisco and London. These locations will house the company’s so-called AI Science Factories, facilities that integrate AI, robotics and laboratory systems to design and run experiments at scale. Lila says these factories have already conducted hundreds of thousands of studies across life science, chemistry and materials science.

Building autonomous science at scale

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now

  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Source link

Continue Reading

AI Research

Gachon University establishes AI·Computing Research Institute – 조선일보

Published

on



Gachon University establishes AI·Computing Research Institute  조선일보



Source link

Continue Reading

AI Research

Tech war: Tencent pushes adoption of Chinese AI chips as mainland cuts reliance on Nvidia

Published

on

By


The Shenzhen-based tech conglomerate’s cloud computing unit, Tencent Cloud, said it was supporting “mainstream domestic chips” in its AI computing infrastructure, without naming any Chinese integrated circuit brand.

Tencent has “fully adapted to mainstream domestic chips” and “participates in the open-source community”, Tencent Cloud president Qiu Yuepeng said at the company’s annual Global Digital Ecosystem Summit on Tuesday.

It is a commitment that reflects growing efforts in the country’s semiconductor industry and AI sector to push forward Beijing’s tech self-sufficiency agenda amid US export restrictions on China and rising geopolitical tensions.
Tencent Cloud unveils support for Chinese-designed AI chips at the company’s annual Global Digital Ecosystem Summit. Photo: Weibo



Source link

Continue Reading

Trending